ConductScience.org, home

Paper33510482

Natural products in drug discovery: advances and opportunities.

Atanasov AG and 4 others. Nat Rev Drug Discov, 2021. Cited by 3,505 papers, by iCite.

Cite this record

ConductScience Library. Natural products in drug discovery: advances and opportunities. Papers, record 33510482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33510482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural products in drug discovery: advances and opportunities.
PubMed
Journal
Nat Rev Drug Discov
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3,505
iCite
Relative citation ratio, by iCite
286
iCite
Revised in PubMed
2026-11-02
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Atanasov AGAtanas Ghttps://orcid.org/0000-0003-2545-0967
2Zotchev SBSergey B
3Dirsch VMVerena Mhttps://orcid.org/0000-0002-9261-5293
4International Natural Product Sciences TaskforceGroup
5Supuran CTClaudiu Thttps://orcid.org/0000-0003-4262-0323

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological ProductsMajor topic
Communicable Diseases
Drug Discovery
Drug Industry
Genome
Humans
Neoplasms

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
MC_UU_12011/4Medical Research CouncilUnited KingdomPubMedPubMed
P 25971Austrian Science Fund FWFAustriaPubMedPubMed
P 27682Austrian Science Fund FWFAustriaPubMedPubMed
P 32109Austrian Science Fund FWFAustriaPubMedPubMed
G12MD007591NIHNIH RePORTER
R01AG066749NIHNIH RePORTER
U24AG047867NIHNIH RePORTER

Download CSV of grants

References192

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126281720Discovery and resupply of pharmacologically active plant-derived natural products: A review.Biotechnol Adv2015https://conductscience.org/library/papers/26281720PubMed
225614221The re-emergence of natural products for drug discovery in the genomics era.Nat Rev Drug Discov2015https://conductscience.org/library/papers/25614221PubMed
326852623Natural Products as Sources of New Drugs from 1981 to 2014.J Nat Prod2016https://conductscience.org/library/papers/26852623PubMed
430315270Treatment of multiple sclerosis - success from bench to bedside.Nat Rev Neurol2019https://conductscience.org/library/papers/30315270PubMed
512546556Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.J Chem Inf Comput Sci2003https://conductscience.org/library/papers/12546556PubMed
626739749The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery.Nat Prod Rep2016https://conductscience.org/library/papers/26739749PubMed
719589993Drug discovery and natural products: end of an era or an endless frontier?Science2009https://conductscience.org/library/papers/19589993PubMed
815602548Lessons from natural molecules.Nature2004https://conductscience.org/library/papers/15602548PubMed
929140691Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers.J Med Chem2018https://conductscience.org/library/papers/29140691PubMed
1025237858Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates.Chem Biol2014https://conductscience.org/library/papers/25237858PubMed
1130212196Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs.J Med Chem2019https://conductscience.org/library/papers/30212196PubMed
1222537178Charting, navigating, and populating natural product chemical space for drug discovery.J Med Chem2012https://conductscience.org/library/papers/22537178PubMed
1323925671Matching the power of high throughput screening to the chemical diversity of natural products.Nat Prod Rep2013https://conductscience.org/library/papers/23925671PubMed
147903979The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents.J Nat Prod1993https://conductscience.org/library/papers/7903979PubMed
1524811496Patenting natural products just got harder.Nat Biotechnol2014https://conductscience.org/library/papers/24811496PubMed
1624650394Emerging R and D law: the Nagoya Protocol and its implications for researchers.ACS Chem Biol2014https://conductscience.org/library/papers/24650394PubMed
1732221504Why a landmark treaty to stop ocean biopiracy could stymie research.Nature2020https://conductscience.org/library/papers/32221504PubMed
1817803898Molecular understanding and modern application of traditional medicines: triumphs and trials.Cell2007https://conductscience.org/library/papers/17803898PubMed
1928685762Opportunities and challenges in phenotypic drug discovery: an industry perspective.Nat Rev Drug Discov2017https://conductscience.org/library/papers/28685762PubMed
2027980341Induced pluripotent stem cell technology: a decade of progress.Nat Rev Drug Discov2017https://conductscience.org/library/papers/27980341PubMed

See all 192 referencesDownload CSV of references

Cited by2,263

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,505 citations.

PMIDTitleJournalYearIn PapersSource
42979297Anti-HIV-1 potential of Tinospora cordifolia extracts: Multi-targeted viral inhibition and immune landscape modulation.J Tradit Complement Med2026https://conductscience.org/library/papers/42979297PubMed
42973815Inhibition of cytochrome P450 activities by juglone in human and rat liver microsomes: kinetic characterization and implications for natural product-drug interaction assessment.Front Pharmacol2026https://conductscience.org/library/papers/42973815PubMed
42972463The therapeutic landscape of cannabidiol: a systematic review of molecular mechanisms, clinical efficacy in oncology and neurology, and regulatory changes.J Cannabis Res2026https://conductscience.org/library/papers/42972463PubMed
42972149From structure prediction to ligand-target recognition: expanding the reach of AlphaFold in natural product research.Nat Prod Bioprospect2026https://conductscience.org/library/papers/42972149PubMed
42964358Clitoria ternatea as a phytopharmacological resource: plant metabolites, mechanistic evidence, translational prospects, and safety considerations.Front Pharmacol2026https://conductscience.org/library/papers/42964358PubMed
42962018Crystalline three-dimensional membranes enable chromatography-free purification of natural products.Sci Adv2026https://conductscience.org/library/papers/42962018PubMed
42957659Omaveloxolone functions as a molecular crowbar-like degrader of STING to alleviate aging-related inflammation.Nat Commun2026https://conductscience.org/library/papers/42957659PubMed
42948731AI-based strategies for diagnosis and therapeutic discovery in pulmonary fibrosis.Chin Herb Med2026https://conductscience.org/library/papers/42948731PubMed
42945003Isolation and structure elucidation of pyridinium-type metabolites from the sponge Agelas nakamurai.J Nat Med2026https://conductscience.org/library/papers/42945003PubMed
42943825Physicochemical Characterization of Liposomal Bilayer Models Loaded with Trans-4-(4'-hydroxy-3'-methoxyphenyl)-5-(1-iodoethyl)dihydrofuran-2-one.Molecules2026https://conductscience.org/library/papers/42943825PubMed
42943732Exploring the Underlying Molecular Mechanisms of Chaetomugilin Q in Breast Cancer Using Network Pharmacology, Molecular Docking, and Bioinformatics.Molecules2026https://conductscience.org/library/papers/42943732PubMed
42943616Genomic Analysis and Advanced Mining of Photorhabdus Isolates Reveal Cryptic Polyketide Synthase Clusters and Potent Anti-Staphylococcal Activity.Microorganisms2026https://conductscience.org/library/papers/42943616PubMed
42943487Immunomodulatory and Metabolic Effects of Ginsenosides Rg1/Rb1 in IBD, RA, and MASLD: Targeting Gut Microbiota-Autoimmunity Axis.Microorganisms2026https://conductscience.org/library/papers/42943487PubMed
42943348A Pathway-Driven Computational Drug Discovery Framework Integrating Machine Learning and Virtual Screening for Identification of Anti-Rheumatoid Arthritis Natural Small Molecules.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943348PubMed
42943265Machine Learning for Screening Bioactive Compounds in Traditional Chinese Medicine: Computational Prediction, Multi-Omics Integration, and Clinical Translation Potential.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943265PubMed
42943257Mechanisms and Therapeutic Advances of Natural Products Regulating Non-Coding RNAs in Cancer.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943257PubMed
42943233Biological Effects of Umbelliferone in MCF-7 Breast Cancer Cells: Integrated In Vitro and Computational Analyses.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943233PubMed
42943058Development of an Efficient Agrobacterium-Mediated Transformation Protocol for the Tetraploid Medicinal and Vegetable Species Solanum villosum Mill.Plants (Basel)2026https://conductscience.org/library/papers/42943058PubMed
42942765Phytosomal Delivery of Natural Bioactives: Advancing Bioavailability, Targeted Drug Delivery, and Clinical Translation.Pharmaceutics2026https://conductscience.org/library/papers/42942765PubMed
42942737LC-MS/MS Quantification of the Anti-Tuberculosis Macrolide Arenicolide A in Rat Plasma: Method Validation and Pharmacokinetic Application.Pharmaceutics2026https://conductscience.org/library/papers/42942737PubMed

See all 2,263 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
KEAP19817PubTator's text mininghttps://conductscience.org/library/genes/9817NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33510482

GET https://conductscience.org/api/papers/v1/33510482/references?page=2